Details of issuance or disposal
Monthly report on the exercise status of stock acquisition rights with exercise price adjustment provisions issued through a third-party allotment
Shares delivered during the month: 0 shares (0 newly issued shares and 0 treasury shares transferred)
Exercise ratio for the relevant month: 0%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Monthly report on the exercise status of stock acquisition rights with exercise price adjustment provisions issued through a third-party allotment |
| Number of shares to be issued or disposed of | Shares delivered during the month: 0 shares (0 newly issued shares and 0 treasury shares transferred) |
| Intended allottee | Name EVO FUND / Subject Series 66 stock acquisition rights / Number of Shares Not disclosed, Name CVI Investments,Inc. / Subject Series 58 stock acquisition rights / Number of Shares Not disclosed |
| Dilution Rate | Exercise ratio for the relevant month: 0% |
| Total number of issued shares | 80,246,460 shares (including 91,244 treasury shares) → 80,246,460 shares (including 91,244 treasury shares)(0%) |
| Exercise price | The exercise price during the relevant month was ¥84 for both the 66th and 58th stock acquisition rights. Details of the exercise price adjustment provisions and the adjustment floor: not disclosed |
| Number of Stock Acquisition Rights | 66th: total issued, 200,000 rights; unexercised at the end of the relevant month, 120,510 rights. 58th: total issued, 20,000 rights; unexercised at the end of the relevant month, 20,000 rights |
| Reason for acquisition without consideration | The 58th stock acquisition rights remaining as of 17 August 2026 were acquired without consideration as of 18 August 2026, and the 66th and 67th stock acquisition rights remaining as of the date hereof were acquired without consideration as of the date hereof |
| Most recent equity financing | Timing 12 August 2025 / Type Issuance of the 65th through 67th stock acquisition rights / Amount Not disclosed, Timing 1 June 2022 / Type Issuance of Series 58 stock acquisition rights / Amount Not disclosed |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The 58th stock acquisition rights are deemed to constitute “MSCB, etc.” in connection with the issuance of the 65th through 67th stock acquisition rights, making disclosure of their monthly exercise status necessary. Disclosure of the monthly exercise status of the 67th stock acquisition rights has been omitted because, under the purchase agreement, they are structured so that, in principle, they cannot be exercised until 13 August 2027.